Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

neuroendocrine neoplasm; neuroendocrine carcinoma; Ki67 labeling index; Ki67 proliferation index; adrenocortical tissues; EMT; epithelial markers; mesenchymal markers; recurrence-free survival; neuroendocrine neoplasms; molecular targeted therapies; mTOR inhibitors; somatostatin analogs; TPH inhibitors; meta-analysis; medullary thyroid cancer; calcitonin; MEN2; gene carriers; adrenocortical cancer; metastatic pheochromocytoma; metastatic paraganglioma; checkpoint inhibitors; avelumab; ipilimumab; nivolumab; pembrolizumab; neuroendocrine tumor; GEP-NET; PET/CT; PRRT; DOTATOC; crcinoid crisis; neuroendocrine tumors; hemodynamic instability; octreotide; neuroendocrine; molecular profiling; targeted therapies; mutation; fusion; ctDNA; anaplastic thyroid carcinoma; chemotherapy; immune checkpoint inhibitors; tumors associated macrophages; radiotherapy; molecular targeted therapy; gastroenteropancreatic neuroendocrine neoplasms; patient-derived xenograft; tumor spheroids; somatostatin receptor-2; near infrared-labelled octreotide analog; management; Delphi; consensus; pancreatic neuroendocrine tumor; everolimus; angiogenesis; circulating cells; biomarkers; n/a